nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Electrocardiogram change—Fluorouracil—head and neck cancer	0.0314	0.033	CcSEcCtD
Salbutamol—Isoprenaline—MAPK1—head and neck cancer	0.0306	0.608	CrCbGaD
Salbutamol—Emotional distress—Hydroxyurea—head and neck cancer	0.0293	0.0308	CcSEcCtD
Salbutamol—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0212	0.0223	CcSEcCtD
Salbutamol—Emotional distress—Fluorouracil—head and neck cancer	0.0211	0.0222	CcSEcCtD
Salbutamol—Ileus—Vinblastine—head and neck cancer	0.0193	0.0203	CcSEcCtD
Salbutamol—Application site reaction—Fluorouracil—head and neck cancer	0.0191	0.0201	CcSEcCtD
Salbutamol—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0152	0.0161	CcSEcCtD
Salbutamol—Clenbuterol—CYP1A1—head and neck cancer	0.0131	0.261	CrCbGaD
Salbutamol—Heartburn—Fluorouracil—head and neck cancer	0.013	0.0137	CcSEcCtD
Salbutamol—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0112	0.0117	CcSEcCtD
Salbutamol—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0111	0.0117	CcSEcCtD
Salbutamol—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00987	0.0104	CcSEcCtD
Salbutamol—Herpes simplex—Fluorouracil—head and neck cancer	0.00973	0.0102	CcSEcCtD
Salbutamol—Heartburn—Docetaxel—head and neck cancer	0.0094	0.0099	CcSEcCtD
Salbutamol—Inflammation—Fluorouracil—head and neck cancer	0.00924	0.00973	CcSEcCtD
Salbutamol—Ileus—Docetaxel—head and neck cancer	0.00914	0.00963	CcSEcCtD
Salbutamol—Angina pectoris—Vinblastine—head and neck cancer	0.00835	0.00879	CcSEcCtD
Salbutamol—Otitis media—Docetaxel—head and neck cancer	0.00831	0.00875	CcSEcCtD
Salbutamol—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00805	0.00848	CcSEcCtD
Salbutamol—Rigors—Docetaxel—head and neck cancer	0.00792	0.00834	CcSEcCtD
Salbutamol—Euphoric mood—Fluorouracil—head and neck cancer	0.0077	0.00811	CcSEcCtD
Salbutamol—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00749	0.00788	CcSEcCtD
Salbutamol—Chest discomfort—Docetaxel—head and neck cancer	0.00731	0.0077	CcSEcCtD
Salbutamol—Dysuria—Hydroxyurea—head and neck cancer	0.00731	0.00769	CcSEcCtD
Salbutamol—Drowsiness—Hydroxyurea—head and neck cancer	0.00697	0.00734	CcSEcCtD
Salbutamol—Haemoglobin—Vinblastine—head and neck cancer	0.00689	0.00726	CcSEcCtD
Salbutamol—Haemorrhage—Vinblastine—head and neck cancer	0.00686	0.00722	CcSEcCtD
Salbutamol—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00683	0.00719	CcSEcCtD
Salbutamol—Hypoaesthesia—Vinblastine—head and neck cancer	0.00682	0.00718	CcSEcCtD
Salbutamol—Pharyngitis—Vinblastine—head and neck cancer	0.00681	0.00717	CcSEcCtD
Salbutamol—Stomatitis—Hydroxyurea—head and neck cancer	0.00679	0.00715	CcSEcCtD
Salbutamol—Inflammation—Docetaxel—head and neck cancer	0.00667	0.00702	CcSEcCtD
Salbutamol—Isoprenaline—CYP1A1—head and neck cancer	0.00657	0.131	CrCbGaD
Salbutamol—Blood pressure increased—Docetaxel—head and neck cancer	0.00647	0.00681	CcSEcCtD
Salbutamol—Haemoglobin—Hydroxyurea—head and neck cancer	0.00629	0.00662	CcSEcCtD
Salbutamol—Haemorrhage—Hydroxyurea—head and neck cancer	0.00625	0.00659	CcSEcCtD
Salbutamol—Irritability—Fluorouracil—head and neck cancer	0.00621	0.00654	CcSEcCtD
Salbutamol—Ataxia—Fluorouracil—head and neck cancer	0.00612	0.00644	CcSEcCtD
Salbutamol—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00582	0.00613	CcSEcCtD
Salbutamol—Lightheadedness—Docetaxel—head and neck cancer	0.00579	0.0061	CcSEcCtD
Salbutamol—Pulmonary oedema—Docetaxel—head and neck cancer	0.00576	0.00606	CcSEcCtD
Salbutamol—Angiopathy—Hydroxyurea—head and neck cancer	0.00567	0.00597	CcSEcCtD
Salbutamol—Chills—Hydroxyurea—head and neck cancer	0.00561	0.00591	CcSEcCtD
Salbutamol—Ill-defined disorder—Vinblastine—head and neck cancer	0.00554	0.00583	CcSEcCtD
Salbutamol—Angina pectoris—Fluorouracil—head and neck cancer	0.00548	0.00577	CcSEcCtD
Salbutamol—Malaise—Vinblastine—head and neck cancer	0.00538	0.00567	CcSEcCtD
Salbutamol—Vertigo—Vinblastine—head and neck cancer	0.00536	0.00565	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00523	0.0055	CcSEcCtD
Salbutamol—Hypertension—Vinblastine—head and neck cancer	0.00515	0.00543	CcSEcCtD
Salbutamol—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00505	0.00532	CcSEcCtD
Salbutamol—Discomfort—Vinblastine—head and neck cancer	0.00502	0.00529	CcSEcCtD
Salbutamol—Atrial fibrillation—Docetaxel—head and neck cancer	0.00496	0.00522	CcSEcCtD
Salbutamol—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00492	0.00518	CcSEcCtD
Salbutamol—Malaise—Hydroxyurea—head and neck cancer	0.00491	0.00517	CcSEcCtD
Salbutamol—Stomatitis—Fluorouracil—head and neck cancer	0.00489	0.00515	CcSEcCtD
Salbutamol—Conjunctivitis—Fluorouracil—head and neck cancer	0.00487	0.00513	CcSEcCtD
Salbutamol—Urinary tract infection—Fluorouracil—head and neck cancer	0.00487	0.00513	CcSEcCtD
Salbutamol—Epistaxis—Fluorouracil—head and neck cancer	0.00473	0.00498	CcSEcCtD
Salbutamol—Sinusitis—Fluorouracil—head and neck cancer	0.0047	0.00495	CcSEcCtD
Salbutamol—Anorexia—Vinblastine—head and neck cancer	0.00464	0.00489	CcSEcCtD
Salbutamol—Migraine—Docetaxel—head and neck cancer	0.00462	0.00487	CcSEcCtD
Salbutamol—Discomfort—Hydroxyurea—head and neck cancer	0.00458	0.00482	CcSEcCtD
Salbutamol—Haemoglobin—Fluorouracil—head and neck cancer	0.00452	0.00476	CcSEcCtD
Salbutamol—Rhinitis—Fluorouracil—head and neck cancer	0.00451	0.00475	CcSEcCtD
Salbutamol—Haemorrhage—Fluorouracil—head and neck cancer	0.0045	0.00474	CcSEcCtD
Salbutamol—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00448	0.00472	CcSEcCtD
Salbutamol—Pharyngitis—Fluorouracil—head and neck cancer	0.00447	0.0047	CcSEcCtD
Salbutamol—Oedema—Hydroxyurea—head and neck cancer	0.00444	0.00468	CcSEcCtD
Salbutamol—Ataxia—Docetaxel—head and neck cancer	0.00442	0.00465	CcSEcCtD
Salbutamol—Infection—Hydroxyurea—head and neck cancer	0.00441	0.00465	CcSEcCtD
Salbutamol—Paraesthesia—Vinblastine—head and neck cancer	0.00437	0.00461	CcSEcCtD
Salbutamol—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00436	0.00459	CcSEcCtD
Salbutamol—Skin disorder—Hydroxyurea—head and neck cancer	0.00432	0.00454	CcSEcCtD
Salbutamol—Abdominal pain upper—Docetaxel—head and neck cancer	0.00429	0.00452	CcSEcCtD
Salbutamol—Anorexia—Hydroxyurea—head and neck cancer	0.00424	0.00446	CcSEcCtD
Salbutamol—Decreased appetite—Vinblastine—head and neck cancer	0.00424	0.00446	CcSEcCtD
Salbutamol—Cramp muscle—Docetaxel—head and neck cancer	0.00423	0.00445	CcSEcCtD
Salbutamol—Nasopharyngitis—Docetaxel—head and neck cancer	0.0042	0.00442	CcSEcCtD
Salbutamol—Pain—Vinblastine—head and neck cancer	0.00417	0.00439	CcSEcCtD
Salbutamol—Constipation—Vinblastine—head and neck cancer	0.00417	0.00439	CcSEcCtD
Salbutamol—Arrhythmia—Fluorouracil—head and neck cancer	0.00402	0.00423	CcSEcCtD
Salbutamol—Feeling abnormal—Vinblastine—head and neck cancer	0.00401	0.00423	CcSEcCtD
Salbutamol—Bronchospasm—Docetaxel—head and neck cancer	0.00399	0.0042	CcSEcCtD
Salbutamol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00398	0.0042	CcSEcCtD
Salbutamol—Dyspnoea—Hydroxyurea—head and neck cancer	0.00396	0.00417	CcSEcCtD
Salbutamol—Angina pectoris—Docetaxel—head and neck cancer	0.00395	0.00416	CcSEcCtD
Salbutamol—Somnolence—Hydroxyurea—head and neck cancer	0.00395	0.00416	CcSEcCtD
Salbutamol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00391	0.00412	CcSEcCtD
Salbutamol—Decreased appetite—Hydroxyurea—head and neck cancer	0.00386	0.00407	CcSEcCtD
Salbutamol—Abdominal pain—Vinblastine—head and neck cancer	0.00385	0.00406	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00384	0.00404	CcSEcCtD
Salbutamol—Fatigue—Hydroxyurea—head and neck cancer	0.00383	0.00403	CcSEcCtD
Salbutamol—Pain—Hydroxyurea—head and neck cancer	0.0038	0.004	CcSEcCtD
Salbutamol—Constipation—Hydroxyurea—head and neck cancer	0.0038	0.004	CcSEcCtD
Salbutamol—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00366	0.00386	CcSEcCtD
Salbutamol—Hypersensitivity—Vinblastine—head and neck cancer	0.00359	0.00378	CcSEcCtD
Salbutamol—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00355	0.00374	CcSEcCtD
Salbutamol—Stomatitis—Docetaxel—head and neck cancer	0.00353	0.00371	CcSEcCtD
Salbutamol—Jaundice—Docetaxel—head and neck cancer	0.00353	0.00371	CcSEcCtD
Salbutamol—Conjunctivitis—Docetaxel—head and neck cancer	0.00352	0.0037	CcSEcCtD
Salbutamol—Body temperature increased—Hydroxyurea—head and neck cancer	0.00351	0.0037	CcSEcCtD
Salbutamol—Asthenia—Vinblastine—head and neck cancer	0.0035	0.00368	CcSEcCtD
Salbutamol—Epistaxis—Docetaxel—head and neck cancer	0.00341	0.00359	CcSEcCtD
Salbutamol—Myalgia—Fluorouracil—head and neck cancer	0.00334	0.00351	CcSEcCtD
Salbutamol—Chest pain—Fluorouracil—head and neck cancer	0.00334	0.00351	CcSEcCtD
Salbutamol—Diarrhoea—Vinblastine—head and neck cancer	0.00333	0.00351	CcSEcCtD
Salbutamol—Discomfort—Fluorouracil—head and neck cancer	0.0033	0.00347	CcSEcCtD
Salbutamol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00327	0.00345	CcSEcCtD
Salbutamol—Haemoglobin—Docetaxel—head and neck cancer	0.00327	0.00344	CcSEcCtD
Salbutamol—Rhinitis—Docetaxel—head and neck cancer	0.00326	0.00343	CcSEcCtD
Salbutamol—Haemorrhage—Docetaxel—head and neck cancer	0.00325	0.00342	CcSEcCtD
Salbutamol—Hypoaesthesia—Docetaxel—head and neck cancer	0.00323	0.0034	CcSEcCtD
Salbutamol—Pharyngitis—Docetaxel—head and neck cancer	0.00322	0.0034	CcSEcCtD
Salbutamol—Dizziness—Vinblastine—head and neck cancer	0.00322	0.00339	CcSEcCtD
Salbutamol—Urinary tract disorder—Docetaxel—head and neck cancer	0.00321	0.00338	CcSEcCtD
Salbutamol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0032	0.00337	CcSEcCtD
Salbutamol—Oedema—Fluorouracil—head and neck cancer	0.0032	0.00337	CcSEcCtD
Salbutamol—Connective tissue disorder—Docetaxel—head and neck cancer	0.00319	0.00336	CcSEcCtD
Salbutamol—Asthenia—Hydroxyurea—head and neck cancer	0.00319	0.00336	CcSEcCtD
Salbutamol—Urethral disorder—Docetaxel—head and neck cancer	0.00318	0.00335	CcSEcCtD
Salbutamol—Infection—Fluorouracil—head and neck cancer	0.00318	0.00335	CcSEcCtD
Salbutamol—Nervous system disorder—Fluorouracil—head and neck cancer	0.00314	0.0033	CcSEcCtD
Salbutamol—Tachycardia—Fluorouracil—head and neck cancer	0.00312	0.00329	CcSEcCtD
Salbutamol—Vomiting—Vinblastine—head and neck cancer	0.0031	0.00326	CcSEcCtD
Salbutamol—Headache—Vinblastine—head and neck cancer	0.00305	0.00321	CcSEcCtD
Salbutamol—Anorexia—Fluorouracil—head and neck cancer	0.00305	0.00321	CcSEcCtD
Salbutamol—Diarrhoea—Hydroxyurea—head and neck cancer	0.00304	0.0032	CcSEcCtD
Salbutamol—Flushing—Docetaxel—head and neck cancer	0.00302	0.00318	CcSEcCtD
Salbutamol—Cardiac disorder—Docetaxel—head and neck cancer	0.00302	0.00318	CcSEcCtD
Salbutamol—Hypotension—Fluorouracil—head and neck cancer	0.00299	0.00315	CcSEcCtD
Salbutamol—Angiopathy—Docetaxel—head and neck cancer	0.00295	0.0031	CcSEcCtD
Salbutamol—Dizziness—Hydroxyurea—head and neck cancer	0.00294	0.00309	CcSEcCtD
Salbutamol—Immune system disorder—Docetaxel—head and neck cancer	0.00293	0.00309	CcSEcCtD
Salbutamol—Mediastinal disorder—Docetaxel—head and neck cancer	0.00293	0.00308	CcSEcCtD
Salbutamol—Chills—Docetaxel—head and neck cancer	0.00292	0.00307	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00291	0.00307	CcSEcCtD
Salbutamol—Arrhythmia—Docetaxel—head and neck cancer	0.0029	0.00306	CcSEcCtD
Salbutamol—Nausea—Vinblastine—head and neck cancer	0.00289	0.00305	CcSEcCtD
Salbutamol—Insomnia—Fluorouracil—head and neck cancer	0.00289	0.00305	CcSEcCtD
Salbutamol—Paraesthesia—Fluorouracil—head and neck cancer	0.00287	0.00302	CcSEcCtD
Salbutamol—Dyspnoea—Fluorouracil—head and neck cancer	0.00285	0.003	CcSEcCtD
Salbutamol—Mental disorder—Docetaxel—head and neck cancer	0.00285	0.003	CcSEcCtD
Salbutamol—Somnolence—Fluorouracil—head and neck cancer	0.00284	0.00299	CcSEcCtD
Salbutamol—Malnutrition—Docetaxel—head and neck cancer	0.00283	0.00298	CcSEcCtD
Salbutamol—Vomiting—Hydroxyurea—head and neck cancer	0.00283	0.00297	CcSEcCtD
Salbutamol—Dyspepsia—Fluorouracil—head and neck cancer	0.00282	0.00296	CcSEcCtD
Salbutamol—Rash—Hydroxyurea—head and neck cancer	0.0028	0.00295	CcSEcCtD
Salbutamol—Dermatitis—Hydroxyurea—head and neck cancer	0.0028	0.00295	CcSEcCtD
Salbutamol—Headache—Hydroxyurea—head and neck cancer	0.00278	0.00293	CcSEcCtD
Salbutamol—Decreased appetite—Fluorouracil—head and neck cancer	0.00278	0.00293	CcSEcCtD
Salbutamol—Dysgeusia—Docetaxel—head and neck cancer	0.00277	0.00292	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00276	0.00291	CcSEcCtD
Salbutamol—Back pain—Docetaxel—head and neck cancer	0.00274	0.00288	CcSEcCtD
Salbutamol—Pain—Fluorouracil—head and neck cancer	0.00273	0.00288	CcSEcCtD
Salbutamol—Muscle spasms—Docetaxel—head and neck cancer	0.00272	0.00286	CcSEcCtD
Salbutamol—Nausea—Hydroxyurea—head and neck cancer	0.00264	0.00278	CcSEcCtD
Salbutamol—Feeling abnormal—Fluorouracil—head and neck cancer	0.00264	0.00278	CcSEcCtD
Salbutamol—Urticaria—Fluorouracil—head and neck cancer	0.00254	0.00268	CcSEcCtD
Salbutamol—Syncope—Docetaxel—head and neck cancer	0.00254	0.00267	CcSEcCtD
Salbutamol—Body temperature increased—Fluorouracil—head and neck cancer	0.00253	0.00266	CcSEcCtD
Salbutamol—Palpitations—Docetaxel—head and neck cancer	0.0025	0.00263	CcSEcCtD
Salbutamol—Loss of consciousness—Docetaxel—head and neck cancer	0.00249	0.00262	CcSEcCtD
Salbutamol—Cough—Docetaxel—head and neck cancer	0.00247	0.0026	CcSEcCtD
Salbutamol—Hypertension—Docetaxel—head and neck cancer	0.00244	0.00257	CcSEcCtD
Salbutamol—Arthralgia—Docetaxel—head and neck cancer	0.00241	0.00254	CcSEcCtD
Salbutamol—Chest pain—Docetaxel—head and neck cancer	0.00241	0.00254	CcSEcCtD
Salbutamol—Myalgia—Docetaxel—head and neck cancer	0.00241	0.00254	CcSEcCtD
Salbutamol—Hypersensitivity—Fluorouracil—head and neck cancer	0.00236	0.00248	CcSEcCtD
Salbutamol—Dry mouth—Docetaxel—head and neck cancer	0.00236	0.00248	CcSEcCtD
Salbutamol—Anaphylactic shock—Docetaxel—head and neck cancer	0.00231	0.00243	CcSEcCtD
Salbutamol—Oedema—Docetaxel—head and neck cancer	0.00231	0.00243	CcSEcCtD
Salbutamol—Infection—Docetaxel—head and neck cancer	0.00229	0.00241	CcSEcCtD
Salbutamol—Shock—Docetaxel—head and neck cancer	0.00227	0.00239	CcSEcCtD
Salbutamol—Nervous system disorder—Docetaxel—head and neck cancer	0.00226	0.00238	CcSEcCtD
Salbutamol—Pruritus—Fluorouracil—head and neck cancer	0.00226	0.00238	CcSEcCtD
Salbutamol—Tachycardia—Docetaxel—head and neck cancer	0.00225	0.00237	CcSEcCtD
Salbutamol—Skin disorder—Docetaxel—head and neck cancer	0.00224	0.00236	CcSEcCtD
Salbutamol—Anorexia—Docetaxel—head and neck cancer	0.0022	0.00232	CcSEcCtD
Salbutamol—Diarrhoea—Fluorouracil—head and neck cancer	0.00219	0.0023	CcSEcCtD
Salbutamol—Hypotension—Docetaxel—head and neck cancer	0.00216	0.00227	CcSEcCtD
Salbutamol—Dizziness—Fluorouracil—head and neck cancer	0.00211	0.00223	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0021	0.00221	CcSEcCtD
Salbutamol—Insomnia—Docetaxel—head and neck cancer	0.00209	0.0022	CcSEcCtD
Salbutamol—Paraesthesia—Docetaxel—head and neck cancer	0.00207	0.00218	CcSEcCtD
Salbutamol—Dyspnoea—Docetaxel—head and neck cancer	0.00206	0.00217	CcSEcCtD
Salbutamol—Somnolence—Docetaxel—head and neck cancer	0.00205	0.00216	CcSEcCtD
Salbutamol—Vomiting—Fluorouracil—head and neck cancer	0.00203	0.00214	CcSEcCtD
Salbutamol—Dyspepsia—Docetaxel—head and neck cancer	0.00203	0.00214	CcSEcCtD
Salbutamol—Rash—Fluorouracil—head and neck cancer	0.00202	0.00212	CcSEcCtD
Salbutamol—Dermatitis—Fluorouracil—head and neck cancer	0.00201	0.00212	CcSEcCtD
Salbutamol—Decreased appetite—Docetaxel—head and neck cancer	0.00201	0.00211	CcSEcCtD
Salbutamol—Headache—Fluorouracil—head and neck cancer	0.002	0.00211	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00199	0.0021	CcSEcCtD
Salbutamol—Fatigue—Docetaxel—head and neck cancer	0.00199	0.0021	CcSEcCtD
Salbutamol—Pain—Docetaxel—head and neck cancer	0.00197	0.00208	CcSEcCtD
Salbutamol—Constipation—Docetaxel—head and neck cancer	0.00197	0.00208	CcSEcCtD
Salbutamol—Feeling abnormal—Docetaxel—head and neck cancer	0.0019	0.002	CcSEcCtD
Salbutamol—Nausea—Fluorouracil—head and neck cancer	0.0019	0.002	CcSEcCtD
Salbutamol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00189	0.00199	CcSEcCtD
Salbutamol—Abdominal pain—Docetaxel—head and neck cancer	0.00182	0.00192	CcSEcCtD
Salbutamol—Body temperature increased—Docetaxel—head and neck cancer	0.00182	0.00192	CcSEcCtD
Salbutamol—Hypersensitivity—Docetaxel—head and neck cancer	0.0017	0.00179	CcSEcCtD
Salbutamol—Asthenia—Docetaxel—head and neck cancer	0.00166	0.00174	CcSEcCtD
Salbutamol—Pruritus—Docetaxel—head and neck cancer	0.00163	0.00172	CcSEcCtD
Salbutamol—Diarrhoea—Docetaxel—head and neck cancer	0.00158	0.00166	CcSEcCtD
Salbutamol—Dizziness—Docetaxel—head and neck cancer	0.00153	0.00161	CcSEcCtD
Salbutamol—Vomiting—Docetaxel—head and neck cancer	0.00147	0.00155	CcSEcCtD
Salbutamol—Rash—Docetaxel—head and neck cancer	0.00146	0.00153	CcSEcCtD
Salbutamol—Dermatitis—Docetaxel—head and neck cancer	0.00145	0.00153	CcSEcCtD
Salbutamol—Headache—Docetaxel—head and neck cancer	0.00145	0.00152	CcSEcCtD
Salbutamol—Nausea—Docetaxel—head and neck cancer	0.00137	0.00144	CcSEcCtD
